Kodiak Sciences (KOD) total liabilities
Kodiak Sciences (KOD) had total liabilities of $194.15M at the end of fiscal 2025 (December 31, 2025). That is 4.8% higher than the $185.29M of fiscal 2024. Figures as of 19 Nov 2026, 00:32 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Total liabilities, fiscal 2025
- $194.15M
- Change on fiscal 2024
- +4.8%
- Growth, 5 years
- −1.2% a year
- Highest on record
- $240.90Mfiscal 2021
- Lowest on record
- $5.36Mfiscal 2018
- Fiscal years on record
- 92017–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Kodiak Sciences total liabilities, in more detail
Over the five fiscal years to 2025 total liabilities shrank at a compound 1.2% a year. Across the 9 fiscal years on record (2017–2025), the highest was $240.90M in fiscal 2021 and the lowest $5.36M in fiscal 2018.
Total liabilities by fiscal year
Kodiak Sciences total liabilities, year by year
| Fiscal year | Total liabilities | Change | Year ended |
|---|---|---|---|
| 2025 | $194.15M | 4.8% up | |
| 2024 | $185.29M | 13.3% down | |
| 2023 | $213.59M | 7.3% down | |
| 2022 | $230.46M | 4.3% down | |
| 2021 | $240.90M | 16.6% up | |
| 2020 | $206.60M | 1,429.5% up | |
| 2019 | $13.51M | 152.2% up | |
| 2018 | $5.36M | 75.6% down | |
| 2017 | $21.97M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.
How to read it
It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.
Total liabilities at health care companies of similar size
| Company | Total liabilities | Fiscal year |
|---|---|---|
| Oruka Therapeutics ORKA | $16.69M | 2025 |
| Arrowhead Pharmaceuticals ARWR | $1.69B | 2026 |
| MSA Safety MSA | $1.19B | 2025 |
| CG Oncology CGON | $38.99M | 2025 |
| Kodiak Sciences KOD | $194.15M | 2025 |
| Lantheus Holdings LNTH | $1.14B | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Kodiak Sciences, figure by figure
- Kodiak Sciences market cap
- Kodiak Sciences revenue
- Kodiak Sciences earnings
- Kodiak Sciences earnings per share (EPS)
- Kodiak Sciences P/E ratio
- Kodiak Sciences P/S ratio
- Kodiak Sciences P/B ratio
- Kodiak Sciences free cash flow
- Kodiak Sciences operating margin
- Kodiak Sciences dividend
- Kodiak Sciences shares outstanding
- Kodiak Sciences total debt
- Kodiak Sciences cash on hand
- Kodiak Sciences total assets
- Kodiak Sciences net assets (shareholders' equity)
- Kodiak Sciences return on equity (ROE)
- Kodiak Sciences return on invested capital (ROIC)
Kodiak Sciences (KOD) overview: price, valuation and scorecardAll health care companies by market value
Kodiak Sciences total liabilities: questions and answers
How large are Kodiak Sciences's total liabilities?
Kodiak Sciences (KOD) had total liabilities of $194.15M at the end of fiscal 2025 (December 31, 2025). That is 4.8% higher than the $185.29M of fiscal 2024.
What is the growth rate of Kodiak Sciences's total liabilities?
Over the five fiscal years to 2025 total liabilities shrank at a compound 1.2% a year.
What are the highest and lowest total liabilities figures on record for Kodiak Sciences?
Across the 9 fiscal years on record (2017–2025), the highest was $240.90M in fiscal 2021 and the lowest $5.36M in fiscal 2018.
How is Kodiak Sciences's total liabilities calculated?
Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Kodiak Sciences it is on record here for 9 fiscal years, 2017 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: total liabilities
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Kodiak Sciences (KOD) total liabilities”, data as of 19 November 2026. https://funkfolio.com/stock/KOD/total-liabilities
Underlying data: the company's filings with the SEC and Yahoo Finance.